Shoulder Innovations, Inc. (SI) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Shoulder Innovations, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Shoulder Innovations, Inc. logo
SI
Shoulder Innovations, Inc.
$399M
$19.26HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$434M
$6.13HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT

Total return — SI vs YDES

growth of $100 · dividends reinvested · last 1y
SI +38.4% (+38.4%/yr)YDES -40.9% (-40.9%/yr)SI compounded faster over this window
50100150200Start $1002026$138$59
SI YDES

SI vs YDES: by the numbers

  • •YDES is the larger company ($434M vs $399M market cap).
  • •Both run net losses; SI's is the smaller (-58.33% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricSIYDES
P/S ratio6.65N/A
P/B ratio3.21N/A

Profitability

MetricSIYDES
Gross margin77.34%-7.06%
Operating margin-58.53%-883.31%
Net margin-58.33%-1392.61%
ROE-28.18%-66.49%
ROIC-25.26%N/A

Go deeper

Full SI analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

Shoulder Innovations ROEYD Bio Limited Ordinary Shares ROEShoulder Innovations operating marginYD Bio Limited Ordinary Shares operating marginShoulder Innovations revenue growthYD Bio Limited Ordinary Shares revenue growthShoulder Innovations free cash flowYD Bio Limited Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.